MIRA vs. PPBT, RDHL, KPRX, IMNN, TNXP, NNVC, AGE, TRAW, EDSA, and MNPR
Should you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Purple Biotech (PPBT), RedHill Biopharma (RDHL), Kiora Pharmaceuticals (KPRX), Imunon (IMNN), Tonix Pharmaceuticals (TNXP), NanoViricides (NNVC), AgeX Therapeutics (AGE), Traws Pharma (TRAW), Edesa Biotech (EDSA), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical preparations" industry.
MIRA Pharmaceuticals (NASDAQ:MIRA) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.
In the previous week, Purple Biotech had 2 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 3 mentions for Purple Biotech and 1 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 0.70 beat Purple Biotech's score of 0.00 indicating that MIRA Pharmaceuticals is being referred to more favorably in the media.
35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 9.6% of Purple Biotech shares are held by institutional investors. 3.0% of Purple Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Purple Biotech has a consensus target price of $9.00, indicating a potential upside of 1,736.73%. Given Purple Biotech's higher probable upside, analysts clearly believe Purple Biotech is more favorable than MIRA Pharmaceuticals.
MIRA Pharmaceuticals' return on equity of 0.00% beat Purple Biotech's return on equity.
Purple Biotech received 12 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users.
Summary
MIRA Pharmaceuticals and Purple Biotech tied by winning 5 of the 10 factors compared between the two stocks.
Get MIRA Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MIRA Pharmaceuticals Competitors List
Related Companies and Tools
